aXichem
2.45 SEK
+7.46 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Financials & Estimates
Ownership
Investor consensus
+7.46 %
-10.58 %
-37.50 %
-1.61 %
+80.81 %
+67.24 %
-82.00 %
-94.64 %
-85.49 %
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.
Read moreMarket cap
144.83M SEK
Turnover
132.42K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
21.5
2026
Interim report Q1'26
17.6
2026
General meeting '26
All
Press releases
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools